HNSCCs have about 60% of mutations in the TP53 gene, where a number of studies reported that TP53 mutations are generally associated with shorter recurrence-free and/or overall survival in these cancers (http://www-p53.iarc.fr). This evidence concerns the gene TP53 and cancer.